{
  "version": "https://jsonfeed.org/version/1.1",
  "title": "PeptideScanner Human Evidence Review changes",
  "home_page_url": "https://peptidescanner.com/synthesis/changes/",
  "feed_url": "https://peptidescanner.com/feeds/synthesis.json",
  "description": "Approved review versions and attributed publisher notices for PeptideScanner Human Evidence Reviews.",
  "items": [
    {
      "id": "living-review-cagrilintide-v1-published",
      "url": "https://peptidescanner.com/peptides/cagrilintide/synthesis/versions/1/",
      "title": "Cagrilintide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 1 explicitly reviewed source snapshot.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-cagrilintide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "cagrilintide",
        "peptideName": "Cagrilintide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Cagrilintide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 1 explicitly reviewed source snapshot.",
        "href": "/peptides/cagrilintide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "34798060",
            "title": "Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34798060/"
          }
        ]
      }
    },
    {
      "id": "living-review-exenatide-v1-published",
      "url": "https://peptidescanner.com/peptides/exenatide/synthesis/versions/1/",
      "title": "Exenatide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-exenatide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "exenatide",
        "peptideName": "Exenatide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Exenatide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/exenatide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "28910237",
            "title": "Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes",
            "url": "https://pubmed.ncbi.nlm.nih.gov/28910237/"
          },
          {
            "authority": "PubMed",
            "recordId": "18803987",
            "title": "Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study",
            "url": "https://pubmed.ncbi.nlm.nih.gov/18803987/"
          }
        ]
      }
    },
    {
      "id": "living-review-leuprolide-v1-published",
      "url": "https://peptidescanner.com/peptides/leuprolide/synthesis/versions/1/",
      "title": "Leuprolide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-leuprolide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "leuprolide",
        "peptideName": "Leuprolide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Leuprolide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/leuprolide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "21300339",
            "title": "Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain",
            "url": "https://pubmed.ncbi.nlm.nih.gov/21300339/"
          },
          {
            "authority": "PubMed",
            "recordId": "32469183",
            "title": "Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer",
            "url": "https://pubmed.ncbi.nlm.nih.gov/32469183/"
          }
        ]
      }
    },
    {
      "id": "living-review-liraglutide-v1-published",
      "url": "https://peptidescanner.com/peptides/liraglutide/synthesis/versions/1/",
      "title": "Liraglutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-liraglutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "liraglutide",
        "peptideName": "Liraglutide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Liraglutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/liraglutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "26132939",
            "title": "A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management",
            "url": "https://pubmed.ncbi.nlm.nih.gov/26132939/"
          },
          {
            "authority": "PubMed",
            "recordId": "27295427",
            "title": "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes",
            "url": "https://pubmed.ncbi.nlm.nih.gov/27295427/"
          }
        ]
      }
    },
    {
      "id": "living-review-octreotide-notice-a8b50863f682ea49-registered",
      "url": "https://peptidescanner.com/peptides/octreotide/synthesis/versions/1/#synthesis-pubmed-34953531-v1",
      "title": "Erratum connected to the Octreotide review",
      "content_text": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-octreotide-notice-a8b50863f682ea49-registered",
        "kind": "publisher-notice-registered",
        "peptideSlug": "octreotide",
        "peptideName": "Octreotide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": "2026-08-19",
        "sourceChangedAt": "2022-03-01",
        "title": "Erratum connected to the Octreotide review",
        "summary": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
        "href": "/peptides/octreotide/synthesis/versions/1/#synthesis-pubmed-34953531-v1",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "34953531",
            "title": "Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34953531/"
          },
          {
            "authority": "Crossref",
            "recordId": "10.1016/s2213-8587(21)00296-5",
            "title": "Crossref integrity metadata for PMID 34953531",
            "url": "https://api.crossref.org/works/10.1016%2Fs2213-8587(21)00296-5"
          },
          {
            "authority": "DOI",
            "recordId": "10.1016/s2213-8587(22)00051-1",
            "title": "Erratum",
            "url": "https://doi.org/10.1016/s2213-8587(22)00051-1"
          }
        ]
      }
    },
    {
      "id": "living-review-octreotide-v1-published",
      "url": "https://peptidescanner.com/peptides/octreotide/synthesis/versions/1/",
      "title": "Octreotide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-octreotide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "octreotide",
        "peptideName": "Octreotide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Octreotide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/octreotide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "2229278",
            "title": "Short term treatment of acromegaly with the somatostatin analog octreotide: the first double-blind randomized placebo-controlled study on its effects",
            "url": "https://pubmed.ncbi.nlm.nih.gov/2229278/"
          },
          {
            "authority": "PubMed",
            "recordId": "34953531",
            "title": "Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34953531/"
          }
        ]
      }
    },
    {
      "id": "living-review-setmelanotide-notice-c40e62f6868127ec-registered",
      "url": "https://peptidescanner.com/peptides/setmelanotide/synthesis/versions/1/#synthesis-pubmed-36356613-v1",
      "title": "Erratum connected to the Setmelanotide review",
      "content_text": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-setmelanotide-notice-c40e62f6868127ec-registered",
        "kind": "publisher-notice-registered",
        "peptideSlug": "setmelanotide",
        "peptideName": "Setmelanotide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": "2026-08-19",
        "sourceChangedAt": "2023-02-01",
        "title": "Erratum connected to the Setmelanotide review",
        "summary": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
        "href": "/peptides/setmelanotide/synthesis/versions/1/#synthesis-pubmed-36356613-v1",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "36356613",
            "title": "Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period",
            "url": "https://pubmed.ncbi.nlm.nih.gov/36356613/"
          },
          {
            "authority": "Crossref",
            "recordId": "10.1016/s2213-8587(22)00277-7",
            "title": "Crossref integrity metadata for PMID 36356613",
            "url": "https://api.crossref.org/works/10.1016%2Fs2213-8587(22)00277-7"
          },
          {
            "authority": "DOI",
            "recordId": "10.1016/s2213-8587(22)00360-6",
            "title": "Erratum",
            "url": "https://doi.org/10.1016/s2213-8587(22)00360-6"
          }
        ]
      }
    },
    {
      "id": "living-review-setmelanotide-v1-published",
      "url": "https://peptidescanner.com/peptides/setmelanotide/synthesis/versions/1/",
      "title": "Setmelanotide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-setmelanotide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "setmelanotide",
        "peptideName": "Setmelanotide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Setmelanotide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/setmelanotide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "33137293",
            "title": "Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials",
            "url": "https://pubmed.ncbi.nlm.nih.gov/33137293/"
          },
          {
            "authority": "PubMed",
            "recordId": "36356613",
            "title": "Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period",
            "url": "https://pubmed.ncbi.nlm.nih.gov/36356613/"
          }
        ]
      }
    },
    {
      "id": "living-review-survodutide-notice-048fbde1fa3ea44e-registered",
      "url": "https://peptidescanner.com/peptides/survodutide/synthesis/versions/1/#synthesis-pubmed-38330987-v1",
      "title": "Erratum connected to the Survodutide review",
      "content_text": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-survodutide-notice-048fbde1fa3ea44e-registered",
        "kind": "publisher-notice-registered",
        "peptideSlug": "survodutide",
        "peptideName": "Survodutide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": "2026-08-19",
        "sourceChangedAt": "2026-02-01",
        "title": "Erratum connected to the Survodutide review",
        "summary": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
        "href": "/peptides/survodutide/synthesis/versions/1/#synthesis-pubmed-38330987-v1",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "38330987",
            "title": "Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38330987/"
          },
          {
            "authority": "Crossref",
            "recordId": "10.1016/s2213-8587(23)00356-x",
            "title": "Crossref integrity metadata for PMID 38330987",
            "url": "https://api.crossref.org/works/10.1016%2Fs2213-8587(23)00356-x"
          },
          {
            "authority": "DOI",
            "recordId": "10.1016/s2213-8587(25)00399-7",
            "title": "Erratum",
            "url": "https://doi.org/10.1016/s2213-8587(25)00399-7"
          }
        ]
      }
    },
    {
      "id": "living-review-survodutide-v1-published",
      "url": "https://peptidescanner.com/peptides/survodutide/synthesis/versions/1/",
      "title": "Survodutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-survodutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "survodutide",
        "peptideName": "Survodutide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Survodutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/survodutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "38330987",
            "title": "Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38330987/"
          },
          {
            "authority": "PubMed",
            "recordId": "38847460",
            "title": "A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38847460/"
          }
        ]
      }
    },
    {
      "id": "living-review-teriparatide-v1-published",
      "url": "https://peptidescanner.com/peptides/teriparatide/synthesis/versions/1/",
      "title": "Teriparatide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-teriparatide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "teriparatide",
        "peptideName": "Teriparatide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Teriparatide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/teriparatide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "11346808",
            "title": "Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis",
            "url": "https://pubmed.ncbi.nlm.nih.gov/11346808/"
          },
          {
            "authority": "PubMed",
            "recordId": "29129436",
            "title": "Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/29129436/"
          }
        ]
      }
    },
    {
      "id": "living-review-tesamorelin-v1-published",
      "url": "https://peptidescanner.com/peptides/tesamorelin/synthesis/versions/1/",
      "title": "Tesamorelin Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-tesamorelin-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "tesamorelin",
        "peptideName": "Tesamorelin",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Tesamorelin Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/tesamorelin/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "18057338",
            "title": "Metabolic effects of a growth hormone-releasing factor in patients with HIV",
            "url": "https://pubmed.ncbi.nlm.nih.gov/18057338/"
          },
          {
            "authority": "PubMed",
            "recordId": "25038357",
            "title": "Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/25038357/"
          }
        ]
      }
    },
    {
      "id": "living-review-tirzepatide-notice-b012c11cb738a2dd-registered",
      "url": "https://peptidescanner.com/peptides/tirzepatide/synthesis/versions/1/#synthesis-pubmed-34186022-v1",
      "title": "Erratum connected to the Tirzepatide review",
      "content_text": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-tirzepatide-notice-b012c11cb738a2dd-registered",
        "kind": "publisher-notice-registered",
        "peptideSlug": "tirzepatide",
        "peptideName": "Tirzepatide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": "2026-08-19",
        "sourceChangedAt": "2021-07-17",
        "title": "Erratum connected to the Tirzepatide review",
        "summary": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
        "href": "/peptides/tirzepatide/synthesis/versions/1/#synthesis-pubmed-34186022-v1",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "34186022",
            "title": "Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34186022/"
          },
          {
            "authority": "Crossref",
            "recordId": "10.1016/s0140-6736(21)01324-6",
            "title": "Crossref integrity metadata for PMID 34186022",
            "url": "https://api.crossref.org/works/10.1016%2Fs0140-6736(21)01324-6"
          },
          {
            "authority": "DOI",
            "recordId": "10.1016/s0140-6736(21)01556-7",
            "title": "Erratum",
            "url": "https://doi.org/10.1016/s0140-6736(21)01556-7"
          }
        ]
      }
    },
    {
      "id": "living-review-tirzepatide-v1-published",
      "url": "https://peptidescanner.com/peptides/tirzepatide/synthesis/versions/1/",
      "title": "Tirzepatide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-tirzepatide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "tirzepatide",
        "peptideName": "Tirzepatide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Tirzepatide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/tirzepatide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "35658024",
            "title": "Tirzepatide Once Weekly for the Treatment of Obesity",
            "url": "https://pubmed.ncbi.nlm.nih.gov/35658024/"
          },
          {
            "authority": "PubMed",
            "recordId": "34186022",
            "title": "Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34186022/"
          }
        ]
      }
    },
    {
      "id": "living-review-bpc-157-v1-published",
      "url": "https://peptidescanner.com/peptides/bpc-157/synthesis/versions/1/",
      "title": "BPC-157 Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-08-18T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-bpc-157-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "bpc-157",
        "peptideName": "BPC-157",
        "version": 1,
        "changedAt": "2026-08-18",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "BPC-157 Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/bpc-157/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "40005999",
            "title": "Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40005999/"
          },
          {
            "authority": "PubMed",
            "recordId": "40131143",
            "title": "Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40131143/"
          },
          {
            "authority": "ClinicalTrials.gov",
            "recordId": "NCT07437547",
            "title": "BPC 157 for Acute Hamstring Muscle Strain Repair",
            "url": "https://clinicaltrials.gov/study/NCT07437547?a=1&tab=history"
          }
        ]
      }
    },
    {
      "id": "living-review-retatrutide-v1-published",
      "url": "https://peptidescanner.com/peptides/retatrutide/synthesis/versions/1/",
      "title": "Retatrutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-18T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-retatrutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "retatrutide",
        "peptideName": "Retatrutide",
        "version": 1,
        "changedAt": "2026-08-18",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Retatrutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/retatrutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "37366315",
            "title": "Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/37366315/"
          },
          {
            "authority": "PubMed",
            "recordId": "37385280",
            "title": "Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA",
            "url": "https://pubmed.ncbi.nlm.nih.gov/37385280/"
          }
        ]
      }
    },
    {
      "id": "living-review-semaglutide-v1-published",
      "url": "https://peptidescanner.com/peptides/semaglutide/synthesis/versions/1/",
      "title": "Semaglutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-18T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-semaglutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "semaglutide",
        "peptideName": "Semaglutide",
        "version": 1,
        "changedAt": "2026-08-18",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Semaglutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/semaglutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "33567185",
            "title": "Once-Weekly Semaglutide in Adults with Overweight or Obesity",
            "url": "https://pubmed.ncbi.nlm.nih.gov/33567185/"
          },
          {
            "authority": "PubMed",
            "recordId": "37952131",
            "title": "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes",
            "url": "https://pubmed.ncbi.nlm.nih.gov/37952131/"
          }
        ]
      }
    }
  ]
}